The ESMO Scale for Clinical Actionability of Molecular Targets, version 2 (ESCAT v2): an evidence-based framework for ranking alterations as actionability and resistance biomarkers in precision oncology
Publication date: Available online 21 October 2026 Source: Annals of Oncology Author(s): A. El Helali, C. Cardone, N. Coleman, J.R. Beal, M.V. Cruz-Ordinario, E. Kocakavuk, M. K-l. Chiu, D. Thomas, C. Turnbull, F. Meric-Bernstam, M.F. Mosele, D. Chakravarty, R. Dienstmann, D. Tamborero, H.E.G. Russnes, M. Kordes, H.H.F. Loong, A. Stenzinger, J. Rueter, D. Martins-Branco
The ESMO Scale for Clinical Actionability of Molecular Targets, version 2 (ESCAT v2): an evidence-based framework for ranking alterations as actionability and resistance biomarkers in precision oncology. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426066512?dgcid=rss_sd_all
The ESMO Scale for Clinical Actionability of Molecular Targets, version 2 (ESCAT v2): an evidence-based framework for ranking alterations as actionability and resistance biomarkers in precision oncology. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426066512?dgcid=rss_sd_all
“The ESMO Scale for Clinical Actionability of Molecular Targets, version 2 (ESCAT v2): an evidence-based framework for ranking alterations as actionability and resistance biomarkers in precision oncology.” Annals of Oncology.
@article{article36298,
title = {The ESMO Scale for Clinical Actionability of Molecular Targets, version 2 (ESCAT v2): an evidence-based framework for ranking alterations as actionability and resistance biomarkers in precision oncology},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426066512?dgcid=rss_sd_all}
}
ABSTRACT Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study...
Abstract Background and Objectives Perioperative blood transfusion in hip arthroplasty is associated with increased morbidity, prolonged hospitalization, and higher costs. This study aimed to identify independent risk factors and...